临床外科杂志
臨床外科雜誌
림상외과잡지
JOURNAL OF CLINICAL SURGERY
2014年
10期
744-745,746
,共3页
尹小平%朱栋良%黎慰浩%王芳元
尹小平%硃棟良%黎慰浩%王芳元
윤소평%주동량%려위호%왕방원
进展期%胃癌术后%营养状态%化疗
進展期%胃癌術後%營養狀態%化療
진전기%위암술후%영양상태%화료
progressive stage%after operation for gastric carcinoma%nutritional status%chemotherapy
目的:观察进展期胃癌术后不同营养状态患者化疗期间的临床状况差异性,探讨营养治疗在营养不良患者化疗期间的临床意义。方法运用营养风险筛查(NRS2002)评价标准,选取进展期胃癌术后NRS>3分的80例患者,随机分为实验组和对照组,每组各40例。实验组患者进行肠外营养支持,对照组除不予肠外营养支持外其余同实验组。比较两组患者的营养生化指标、化疗毒副反应。结果实验组和对照组在营养生化指标、化疗毒副反应评分差异上有统计学意义(P<0.05)。结论营养不良状态是影响胃癌术后化疗的不利因素,降低化疗耐受力、生活质量,影响胃癌术后化疗的临床转归,营养支持治疗使营养不良患者化疗期间临床受益。
目的:觀察進展期胃癌術後不同營養狀態患者化療期間的臨床狀況差異性,探討營養治療在營養不良患者化療期間的臨床意義。方法運用營養風險篩查(NRS2002)評價標準,選取進展期胃癌術後NRS>3分的80例患者,隨機分為實驗組和對照組,每組各40例。實驗組患者進行腸外營養支持,對照組除不予腸外營養支持外其餘同實驗組。比較兩組患者的營養生化指標、化療毒副反應。結果實驗組和對照組在營養生化指標、化療毒副反應評分差異上有統計學意義(P<0.05)。結論營養不良狀態是影響胃癌術後化療的不利因素,降低化療耐受力、生活質量,影響胃癌術後化療的臨床轉歸,營養支持治療使營養不良患者化療期間臨床受益。
목적:관찰진전기위암술후불동영양상태환자화료기간적림상상황차이성,탐토영양치료재영양불량환자화료기간적림상의의。방법운용영양풍험사사(NRS2002)평개표준,선취진전기위암술후NRS>3분적80례환자,수궤분위실험조화대조조,매조각40례。실험조환자진행장외영양지지,대조조제불여장외영양지지외기여동실험조。비교량조환자적영양생화지표、화료독부반응。결과실험조화대조조재영양생화지표、화료독부반응평분차이상유통계학의의(P<0.05)。결론영양불량상태시영향위암술후화료적불리인소,강저화료내수력、생활질량,영향위암술후화료적림상전귀,영양지지치료사영양불량환자화료기간림상수익。
Objective To observe the clinical differences of postoperative nutritional status inchemotherapy patients with advanced gastric carcinoma and discuss the significance of nutritional therapy.Method According to the Nutritional Risk Screening 2002(NRS 2002),80 patients(NRS score >3)wererandomly divided into the experimental group(n =40)and control group(n =40).Patients in the experimental group received additional parenteral nutrition.Patients in the control group received the same treatment except for the parenteral nutrition.Nutritional biochemistry indexes,toxicities and side reactions ofthe chemotherapy were compared between the groups.Results There were significant differences in nutritional biochemistry indexes,toxicities and side reactions of the chemotherapy between the groups(P <0.05).Conclusion Poor nutrition status is a negative factor of postoperative chemotherapy for patientswith gastric carcinoma.It will reduce chemotherapy tolerance and quality of life,which has negative effectson the clinical outcomes of postoperative chemotherapy.Nutrition support will benefit those patients whohad malnutrition during the time of chemotherapy.